Understanding recent haemoglobin trials in CKD: methods and lesson learned from CREATE and CHOIR

被引:59
作者
Levin, Adeera [1 ]
机构
[1] Nephrol Educ & Res, Vancouver, BC V6Z 1Y6, Canada
关键词
D O I
10.1093/ndt/gfl824
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 [基础医学]; 1002 [临床医学]; 100602 [中西医结合临床];
摘要
引用
收藏
页码:309 / 312
页数:4
相关论文
共 10 条
[1]
Normalization of hemoglobin level in patients with chronic kidney disease and anemia [J].
Drueke, Tilman B. ;
Locatelli, Francesco ;
Clyne, Naomi ;
Eckardt, Kai-Uwe ;
Macdougall, Iain C. ;
Tsakiris, Dimitrios ;
Burger, Hans-Ulrich ;
Scherhag, Armin .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2071-2084
[2]
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy [J].
Foley, RN ;
Parfrey, PS ;
Morgan, J ;
Barré, PE ;
Campbell, P ;
Cartier, P ;
Coyle, D ;
Fine, A ;
Handa, P ;
Kingma, I ;
Lau, CY ;
Levin, A ;
Mendelssohn, D ;
Muirhead, N ;
Murphy, B ;
Plante, RK ;
Posen, G ;
Wells, GA .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1325-1335
[3]
Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial [J].
Gouva, C ;
Nikolopoulos, P ;
Ioannidis, JPA ;
Siamopoulos, KC .
KIDNEY INTERNATIONAL, 2004, 66 (02) :753-760
[4]
Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD [J].
Levin, A ;
Djurdjev, O ;
Thompson, C ;
Barrett, B ;
Ethier, J ;
Carlisle, E ;
Barre, P ;
Magner, P ;
Muirhead, N ;
Tobe, S ;
Tam, P ;
Wadgymar, JA ;
Kappel, J ;
Holland, D ;
Pichette, V ;
Shoker, A ;
Soltys, G ;
Verrelli, M ;
Singer, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (05) :799-811
[5]
Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin [J].
Levin, A ;
Thompson, CR ;
Ethier, J ;
Carlisle, EJF ;
Tobe, S ;
Mendelssohn, D ;
Burgess, E ;
Jindal, K ;
Barrett, B ;
Singer, J ;
Djurdjev, O .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (01) :125-134
[6]
Macdougall I. C., NEPHROL DIAL TRANSPL
[7]
Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure [J].
McMahon, LP ;
Mason, K ;
Skinner, SL ;
Burge, CM ;
Grigg, LE ;
Becker, GJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (09) :1425-1430
[8]
Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease [J].
Parfrey, PS ;
Foley, RN ;
Wittreich, BH ;
Sullivan, DJ ;
Zagari, MJ ;
Frei, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :2180-2189
[9]
Effects of early and late intervention with epoetin α on left ventricular mass among patients with chronic kidney disease (Stage 3 or 4):: Results of a randomized clinical trial [J].
Roger, SD ;
McMahon, LP ;
Clarkson, A ;
Disney, A ;
Harris, D ;
Hawley, C ;
Healy, H ;
Kerr, P ;
Lynn, K ;
Parnham, A ;
Pascoe, R ;
Voss, D ;
Walker, R ;
Levin, A .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (01) :148-156
[10]
Correction of anemia with epoetin alfa in chronic kidney disease [J].
Singh, Ajay K. ;
Szczech, Lynda ;
Tang, Kezhen L. ;
Barnhart, Huiman ;
Sapp, Shelly ;
Wolfson, Marsha ;
Reddan, Donal .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2085-2098